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Dynamic studies of aldosterone in anephric man. Aldosterone
metabolism in the absence of a functioning renin-angiotensin
system was evaluated in twelve anephric subjects. Plasma aldo-
sterone concentrations determined while subjects were in a
supine position were usually low, correlated with the plasma
potassium concentration (r= 0.38; P< 0.01) and responded to
acute alterations in plasma potassium concentration (r =0.64;
P<0.00l), thus indicating an important role for potassium in
aldosterone regulation in anephric man. In contrast, plasma
aldosterone concentration did not increase following volume
and sodium depletion with ultrafiltration hemodialysis. Its re-
sponse to angiotensin and corticotropin administration was
usually diminished. We felt this was due in part to potassium
depletion secondary to maintenance hemodialysis, since potas-
sium repletion in two subjects improved aldosterone respon-
siveness. Another factor in the diminished aldosterone respon-
siveness in anephric subjects may be renin deficiency. Upright
posture caused increases in plasma aldosterone concentration
which could not be explained by concomitant alterations in
the concentrations of adrenocorticotropic hormone (ACTH) or
plasma electrolytes or metabolic clearance rate of aldosterone.
Etudes dynamiques de l'aldostérone chez l'homme anephrique.
Le métabolisme de l'aldostérone en l'absence d'un système
rénine angiotensine fonctionnel a dté évalué chez douze sujets
anéphriques. Les concentrations d'aldostérone en position de-
bout étaient habituellement basses, corrélées avec Ia kaliémie
(r= 0,38; P<0,Ol) et répondaient aux modifications aigues de
Ia kaliémie (r= 0,64; P< 0,001), ce qui indique un role important
du potassium dans Ia regulation de l'aldostérone chez l'homme
anéphrique. Au contraire, Ia concentration d'aldostérone du
plasma n'a pas augmenté après une déplétion d'eau et de sodium
réalisée par ultrafiltration au cours de l'hemodialyse. La réponse
a l'angiotensine et a I'ACTH était habituellement diminuée. Il
est propose que cela soit du en partie a Ia déplétion en potassium
secondaire a l'hémodialyse chronique puisque la recharge en
potassium chez deux sujets a amélioré Ia réponse aux stimuli.
Un autre facteur dans Ia diminution de Ia réponse chez les
sujets anéphriques peut être le deficit de rénine. La position
debout a déterminé des augmentations de l'aldostérone du
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plasma qui ne peuvent pas être expliquees par des modifications
concomitantes de 1'ACTH, des electrolytes du plasma ou du
debit de la clearance métabolique de l'aldostérone.
Four factors are known to directly stimulate aldosterone
secretion. These are renin through its mediator anglo-
tensin II, adrenocorticotropic hormone (ACTH), potas-
sium and sodium [1—61. The renin-angiotensin system is
generally considered to be the primary regulator of aldos-
terone secretion rate under normal conditions. Anephric
man, where renal renin is absent, provides an interesting
model in which to observe the role of other potential con-
trol mechanisms. Data of this type obtained from other
studies have been limited and conflicting [7—10]. The pre-
sent report, based on our findings in twelve anephric sub-
jects, includes observations on the acute effects of changes
in serum potassium concentrations, hemodialysis and
posture on plasma aldosterone concentration and aldos-
terone clearance rates. The study also provides information
on the adrenal response in these patients to the administra-
tion of angiotensin and ACTH. The results indicate the
complexity of aldosterone control in anephric man.
Methods
Twelve anephric patients were studied, eight men and
four women with an age range of 22 to 57 years. Bilateral
nephrectomy was performed for treatment of otherwise un-
controllable hypertension in nine patients and in prepara-
tion for a kidney allograft in three. The removed kidneys
showed nephrosclerosis in six, glomerulonephritis in four
and pyelonephritis in two patients. The time interval be-
tween nephrectomy and the tests included in this study
ranged from 2 weeks to 35 months. During the course of
this study, three of the twelve anephric subjects were con-
sistently normotensive; the other nine had intermittent
mild to moderate salt and water-dependent hypertension
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that was reversible by sodium restriction and ultrafiltration
dialysis. Nine patients were maintained by biweekly eight-
hour hemodialysis in the hospital unit, and three patients
dialyzed themselves 20 to 28 hours per week at home. The
standard dialysate contained 0 or I mEq/liter of potassium
and 132 mEq/liter of sodium. All patients were instructed
to restrict their fluid intake and to follow a diet containing
1.0 g of sodium and 1.5 g or less of potassium.
Weight, blood pressure and plasma concentrations of
sodium, potassium, aldosterone and cortisol and renin
activity were measured before and after the following
maneuvers: 1) oral administration of 60 mEq of potassium
as potassium chloride (seven patients); 2) four hours of
hemodialysis without ultrafiltration against potassium-free
dialysate (six of these seven acutely potassium loaded
patients); 3) seven hours of hemodialysis with ultrafiltration
against potassium-free or poor (1 mEq/liter) dialysate
(14 tests in seven patients); 4) seven hours of hemodialysis
with ultrafiltration against a dialysate potassium concen-
tration of 4.5 mEq/liter (six patients); 5) a four-hour inf u-
sion of heparin at a rate of 10 to 15 mg/hour, the infusion
rate being equal to the patient's usual heparin dosage during
hemodialysis (six patients); 6) a one-hour infusion of
angiotensin II at a rate sufficient to maintain a diastolic
blood pressure of 20 mm Hg above baseline (twelve tests in
ten patients) [11]; 7) a two-hour infusion of a synthetic
ACTH (Cortrosyn cc1 24, Organon Inc.) at a rate of 0.1 mg
(approximately 10 USP units of ACTH) per hour (11 tests
in nine patients); and 8) one hour of ambulation without
(nine patients) or with (four patients) previous administra-
tion of dexamethasone, 1 mg at midnight and 1 mg be-
tween 6 and 7 AM before the test. Six additional orthostatic
studies were performed in conjunction with measurements
of the metabolic clearance rates of aldosterone after two
hours supine and two hours of quiet standing (six patients).
All control samples were obtained after the patients were
supine for at least one hour. With the exception of the
postural studies, the patients remained supine throughout
the test. Each patient gave his informed consent before
undergoing any of the studies.
Plasma sodium and potassium concentrations were deter-
mined by a flame photometer (Instrumentation Laboratory),
and plasma renin activity (PRA) by the method of Bou-
cher et al [12]. The lowest PRA that is detectable by this
method is 30 ng/l00 ml/3 hours of incubation. In our
laboratory, the normal values derived from thirteen normal
subjects maintained on a sodium intake of 100 to 150 mEq/
day, are 225 185 ng/100 ml (mean SD) after one hour
of recumbency and 530 280 ng/100 ml after one hour of
ambulation.
Plasma aldosterone concentration was measured by
radioimmunoassay [13]. Normal ranges are the following:
supine position for one hour, 7.2± 2.7 (mean± SD) ng/
100 ml; standing for one hour, 29.5 11.0ng/100 ml; fol-
lowing a standard infusion [11] of angiotensin IL for one
hour, 43.8 16.4 ng/100 ml; following a one-hour infusion
of ACTH, 26.0± 14.7 ng/100 ml, and a two-hour infusion,
18.8 7.2 ng/l00 ml. The radioimmunoassay has a limit
of detection of 0.3 ng/100 ml using 2 ml of plasma [13].
The metabolic clearance rate of aldosterone was deter-
mined by the constant infusion of 3H-aldosterone using the
technique of Bougas Ct al [14]. Blood samples were ob-
tained at 105 and 120 minutes following the loading dose
and the start of infusion in the supine position, and again
at the same intervals after the change from supine to stand-
ing. In normal subjects, the metabolic clearance rate of
aldosterone is 1,660± 290 (SD) liters/day [15]. It is calcu-
lated as counts per minute infused per day divided by
counts per minute per liter of plasma corrected for losses
during purification using '4C-aldosterone as an indicator.
The secretion rate of aldosterone is calculated as the
product of the mean plasma aldosterone concentration and
the metabolic clearance rate [15]. Plasma cortisol concen-
tration was measured by a competitive protein binding
assay [16].
A paired data t test was used for the statistical analysis
of measurements taken before and after the different test
procedures [17]. For this purpose, undetectable plasma
aldosterone concentrations (less than 0.3 ng/lOO ml) were
arbitrarily assigned a value of 0.15 ng/100 ml. However,
undetectable aldosterone concentrations were excluded
from the linear regression analysis of the baseline plasma
aldosterone concentrations on potassium concentration.
The natural logarithm of the plasma aldosterone values
was used for the statistical analyses.
Results
Plasma renin activity. The plasma renin activity of sub-
jects in the supine position was undetectable in eleven of
twelve individuals and remained undetectable during stand-
ing (N= 11), acute volume depletion by ultrafiltration
(N = 10) and following infusions of angiotensin II (N= 9),
ACTH (N= 6) and heparin (N= 6). In the twelfth patient,
a 34-year-old woman, baseline PRA on four occasions
ranged from 30 to 50 ng/lOO ml (normal, 30 to 600 ng/
100 ml) and was unchanged during standing, after ultra-
filtration and following administration of angiotensin and
ACTH.
Correlation between plasma aldosterone and potassium
values. Baseline plasma aldosterone concentrations of sub-
jects in the supine position ranged from less than 0.3 to
18 ng/100 ml, with the majority of values being subnormal
(Fig. 1, left). Aldosterone concentrations three or four
days following hemodialysis tended to be higher than those
observed on the first two days after dialysis. Analysis of
values from seven of the twelve patients in whom paired
data were obtained showed that this increase in aldosterone
concentration was significant (P<0.05) and that it was
associated with a significant increase in plasma potassium
concentration (P<0.05) (Fig. 1, right), in weight (P<0.05)
and in blood pressure (P<0.05). When the supine baseline
Fig. 1. Left, Baseline plasma aldo-
sterone concentrations obtained in
the twelve anephric subjects after
one hour in supine position. Right,
Plasma aldosterone and potassium
concentration in seven supine ane-
phric subjects on the first and se-
cond, as compared to the third and
fourth, days following hemodialysis.
aldosterone values were plotted against the corresponding
plasma potassium concentrations, there was a statistically
significant but rather weak correlation between these two
factors (r=0.38; P<0.0l) (Fig. 2). Utilizing multivariate
analysis of variance (taking out the effect of the between-
patient differences), the correlation was r =0.35, a value
not significantly different from the original analysis.
Effect of acute alterations in plasma potassium concentra-
tion (Fig. 3). Two hours following an orally administered
potassium load of 60 mEq, significant increases in the con-
centrations of both plasma potassium (mean increase,
1.09 mEq/liter; P< 0.001) and plasma aldosterone (mean in-
crease, 2.66 ng/100 ml; P<0.0025) could be observed while
plasma sodium concentration, weight and blood pressure
did not change significantly.
In these potassium-loaded patients, hemodialysis with-
out ultrafiltration against potassium-free dialysate for four
hours was associated with consistent significant de-
creases in the concentrations of both plasma potassium
(mean decrease, 2.05 mEq/liter; P<0.001) and plasma
Plasma
Potassium
mEq litter
aldosterone (mean decrease, 2.9 ng/100 ml; P< 0.005);
plasma sodium concentration, weight and mean blood
pressure did not change significantly.
Hemodialysis with ultrafiltiation against potassium-free
or -poor dialysate was associated with significant decreases
in all indexes measured: mean plasma aldosterone value
fell 3.11 ng/100 ml (P<0.005); mean plasma potassium
concentration, 1.64 mEq/liter (P< 0.001); mean plasma
sodium concentration, 3.7 mEq/liter (P< 0.001); mean
weight, 2.14 kg (P<0.OOl); and mean blood piessure,
20mm Hg (P<0.00l).
The decreases in plasma sodium concentration, weight
and mean blood pressure seen following ultrafiltration
dialysis against low potassium dialysate were comparable
with those observed when the patients underwent ultra-
filtration dialysis against a dialysate potassium concentra-
tion of 4.5 mEq/liter. However, neither plasma aldosterone
nor potassium concentration changed significantly with
the use of higher potassium concentrations in the dialysate
(Fig. 3).
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Linear regression analysis of all potassium loading and
hemodialysis studies revealed a significant positive coriela-
tion between the acute changes in plasma potassium and
the corresponding changes in plasma aldosterone (r= 0.64;
.
.
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Plasma potassium, mEq/liter
P<0.000l) (Fig. 4). In addition, there was also a positive
correlation between the alterations in plasma sodium
values which, under the study conditions used, usually
paralleled the changes in potassium and aldosterone values
(r= 0.46; P< 0.01). No significant correlation was observed
between the alterations in aldosterone concentration and
the accompanying changes in weight or mean blood
pressure.
Effect of heparin administration. No consistent change in
plasma aldosterone concentrations was observed following
four hours of heparin infusion; the mean values were
2.32± 2.33 (SD) before and 1.96± 0.94 ng/lOOml following
the infusion.
Adrenal responsiveness to angiotensin II and corticotropin
administration. The response of plasma aldosterone to the
infusion of a standard pressor dose of angiotensin (range,
6.4 to 39.5; mean, 15.0 ng/kg/min) for one hour was blunted
or absent in eight of the ten patients studied. Subjects with
the lower baseline aldosterone concentrations were usually
less responsive (Table 1). Similarly blunted or absent re-
sponses were seen in several patients following a two-hour
infusion of corticotropin (Table 2).
Baseline plasma cortisol concentrations were normal and
fell slightly with angiotensin infusion, but increased two-
to more than four-fold following administration of syn-
thetic ACTH (Tables I and 2). Serum electrolyte values
and weight did not change significantly with the two inf u-
sions, nor was there any change in blood pressure during
the administration of ACTH.
Patients 8 and 10 were maintained by heinodialysis using
potassium-free dialysate and were suspected to be potas-
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Fig. 4. Correlation between changes in the concentrations of
plasma aldosterone and plasma potassium following potassium
loading and hemodialysis in anephric subjects. N= 34, y=
1.95 X + 0.628, r=0.640, P<0.000l.
<0.3J
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Fig. 2. Correlation between plasma aldosterone and potassium
concentrations obtained from twelve anephric subjects in the
supine position. The undetectable values are not included in the
regression analysis. N—66, log y=O.44x —1.13, r=O.38,
F< 0.01.
Fig. 3. Effect of oral administration of potassium and hemodialysis
on plasma concentrations of aldosterone, potassium and sodium
and on weight and blood pressure in anephric subjects.
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Table 1. Effect of angiotensin II administration on plasma aldosterone, cortisol, potassium and sodium concentrations
in anephric subjects
Baseline Angiotensin Aldosterone a Cortisol Potassium Sodium
Patient blood pressure pressor dose
mmHg ng/kg/min Cb A11c Cb A1C Cb A11° Cb A11°
ng/100 ml pg/100 ml mEq/liter mEq/liter
1 174/110 8.6 3.1 11.6 — — 3.3 3.3 123 122
2 182/99 9.5 3.1 21.0 — — 3.3 3.4 136 136
3 170/108 39.5 1.7 5.1 — — 3.8 4.0 135 136
4 170/105 7.8 0.85 0.9 — 3.8 4.1 134 136
5 118/64 12.6 1.1 <0.5 13.4 12.1 2.7 2.7 139 139
6 148/92 12.5 <0.3 <0.3 11.8 11.4 4.0 4.0 138 137
7 111/82 6.4 <0.3 2.4 9.6 8.0 3.3 3.5 129 130
8 134/90 14.4 <0.3 <0.3 12.4 11.2 3.6 3.8 134 133
10 174/107 21.7 0.5 0.5 8.6 8.3 3.6 3.5 127 124
11 154/121 17.1 1.0 1.5 9.7 7.9 4.0 3.9 132 130
Mean 154/98 15.0 1.18 4.34 10.92 9.82 3.54 3.62 132.7 132.3
SD 25/16 9.8 1.13 6.85 1.88 1.94 0.40 0.43 5.0 5.7P NS <0.01 NS NS
a Normal mean SD: C, 7.2 2.7; A11, 43.8 16.4.
a C = control.
A11 = following angiotensin II infusion.
Table 2. Effect of corticotropin administration on plasma aldosterone, cortisol, potassium and sodium concentrations
in anephric patients
Aldosterone a Cortisol Potassium Sodium
Patient C 60'C 120'd Cb 61J'C 120'd Ca j'o 120'd Ca 60'C 120'd
ng/100 ml pg/100 ml mEq/liter mEq/liter
1 1.0 10.6 8.0 5.0 15.8 21.6 4.1 4.0 3.9 133 133 133
2 0.8 0.8 1.0 9.8 16.8 19.5 2.5 2.6 2.6 134 135 135
3 2.5 20.6 22.2 12.5 23.0 29.0 5.4 5.5 5.9 138 139 139
4 2.2 1.2 2.9 16.0 19.5 29.0 3.1 3.2 3.3 135 137 138
5 1.8 5.5 3.0 12.9 17.9 30.2 4.6 4.5 4.5 141 141 139
7 1.5 1.3 1.8 8.2 24.4 36.0 4.4 4.5 4.5 141 140 141
8 0.5 1.5 1.5 11.7 26.4 35.4 2.5 2.5 2.5 135 134 134
10 0.7 3.1 2.0 12.8 32.0 39.0 3.3 3.3 3.3 140 140 140
11 0.8 1.4 1.2 12.4 24.0 25.8 4.0 4.0 4.1 128 128 128
Mean 1.31 5.11 4.84 11.26 22.20 29.50 3.77 3.79 3.84 136.1 136.3 136.3
SD 0.72 6.61 6.85 3.19 5.22 6.56 0.99 0.98 1.07 4.3 4.2 4.2
P <0.025 <0.05 <0.005 <0.005 NS NS NS NS
a Normal mean SD: C, 7.2 2.7; 60', 26.0 14.7; 120', 18.8 7.2.
C = control.
60' = following administration of corticotropin for one hour.
d 120' = following administration of corticotropin for two hours.
slum-depleted (Tables I and 2). Therefore, the angiotensin
and ACTI-TI infusions were repeated following two weeks
of hemodialysis using a dialysate potassium concentration
of 2 mEq/liter in patient 8 and 3 mEq/liter in patient 10.
This maneuver increased the baseline plasma potassium
concentrations in patient 8 from 3.6 to 4.9 mEq/liter prior
to angiotensin infusion, and from 2.5 to 5.4 mEq/liter be-
fore corticotropin infusion; in patient 10, the comparable
changes were 3.6 to 4.7 and 3.3 to 4.6 mEq/liter, respectively.
In both patients the increased potassium concentrations were
associated with an increase in baseline plasma aldosterone
values as well as with an improved responsiveness of aldo-
sterone following administration of both stimuli (Fig. 5).
Effect of upright posture (Tables 3 and 4). In 9 of the
19 postural studies, assumption of the upright posture
caused no clear-cut changes in plasma aldosterone concen-
tration (Table 3, patients 2A, 2B, 4, 6A, 6B, 8B, bA,
11, 12). It should be noted that baseline plasma aldosterone
concentrations were very low (<1 ng/100 ml) in all but
one and that potassium-free dialysate was utilized in seven
of these nine studies in which there was no change in
plasma aldosterone concentration.
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Table 3. Effect of upright posture on blood pressure and plasma aldosterone, cortisol, potassium and sodium concentrations
in anephric subjects
Patient Study Blood pressure Aldosterone Cortisol Potassium Sodium
Sa Ub Sa Ub Sa ub Sa ub sa u
mm Hg ng/100 ml pg/100 ml mEq/ liter mEq/liter
1 A 140/95 150/105 9.6 17.8 3.8 2.2 4.4 4.4 127 126
1 B (D)C 135/95 125/95 4.5 19.4 0 0 3.75 3.75 126 126
1 C 235/136 208/120 6.6 13.2 12.5 5.6 4.4 4.4 142 138
2 A 176/114 174/110 0.95 0.9 9.2 10.4 3.75 3.7 135 135
2 B (D)C 190/105 195/110 <0.3 <0.3 — — 4.3 4.45 136 136
3 — 182/104 130/90 1.4 2.1 6.5 10.0 4.1 4.0 136 136
4 — 140/80 138/75 <0.3 <0.3 14.0 12.8 4.45 4.45 134 132
5 A 100/60 98/50 0.7 1.4 12.8 10.9 4.2 4.6 138 136
5 B 118/72 108/60 2.6 4.0 — — 3.5 — — —
6 A 152/96 154/94 0.35 0.3 — — 4.0 4.0 133 133
6 B (D)° 145/95 140/92 0.3 0.35 — — 3.8 3.7 132 131
7 — 170/100 140/90 2.5 6.2 — — 4.4 4.4 — —
8 A 150/95 85/45 <0.3 1.2 8.4 12.8 4.6 4.2 131 131
8 B (D)° 130/65 80/40 <0.3 0.7 — — 4.0 4.0 135 134
9 — 180/105 160/100 10.9 21.1 — — 4.2 4.2 — —
10 A 160/94 142/102 0.8 0.8 10.2 12.5 4.3 4.3 136 136
10 B 152/78 84/50 1.8 5.6 13.0 4.2 3.8 3.7 138 136
11 — 202/130 174/126 0.7 1.0 12.8 10.9 5.1 5.0 137 136
12 — 168/118 120/78 2.9 3.5 13.4 15.2 3.8 4.0 131 136
a S = supine.b u = upright.
C (D)= following dexamethasone administration.
Table 4. Effect of upright posture on plasma concentration, metabolic clearance rate, and secretion rate of aldosterone
in six anephrix subjects
Patient Vascular Plasma concentration Metabolic clearance rate Secretion rate
short
circuit Sa Ub Sa Ub A% Sa Ub
ng/100 ml liter/24 hr pg/24 hr
i Fe 6.6 13.2 +100.0 2534 2118 —16.4 167.2 279.6 +67.2
5 Shd 2.6 4.0 + 53.9 951 650 —32.8 24.7 26.0 + 4.8
7 Sh 2.5 6.2 +148.0 1285 650 —49.4 32.1 40.3 +25.5
9 She 10.9 21.1 + 93.6 1530 1165 —23.9 166.8 245.8 + 47.4
10 Sh+FC 1.8 5.6 +211.1 3540 2700 —23.7 63.7 151.2 +137.4
12 F' 2.9 3.5 + 20.7 2173 1646 —24.2 63.0 57.6 — 8.7
Mean 4.55 8.93 +104.6 2002 1488 —28.4 86.2 133.4 + 45.6
SD 3.54 6.91 67.8 951 825 11.5 64.5 109.8 52.8
P <0.01 <0.001 <0.05
a =supine.
b U=upnght.
C F arteriovenous fistula.
d Sh = arteriovenous shunt.
In the remaining ten tests, the change from the supine
to the upright position was associated with an increase in
plasma aldosterone concentration of 50% or more (Table 3,
patients IA, 1B, 1C, 3, 5A, 5B, 7, 8A, 9, lOB). Baseline
aldosterone concentrations were more than 1 ng/100 ml in
eight of these ten tests, and maintenance hemodialysis was
performed with a hemodialysate potassium concentration
of 1 to 2 mEq/liter. There was no consistent change in
plasma cortisol concentration in the upright position. Sup-
pression of ACTH with dexamethasone therapy did not
alter the postural response of plasma aldosterone in pa-
tient 1; in the other three patients to whom dexamethasone
was administered, the plasma aldosterone concentrations
were too low for adequate interpretation (Table 3). Plasma
sodium and potassium values did not change with standing.
Simultaneous measurements of plasma concentration
and metabolic clearance rate of aldosterone in both the
supine and standing positions were obtained in six anephric
patients (Table 4). These subjects were selected because
their plasma aldosterone concentrations were higher than
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those found in the other anephric subjects. Metabolic
clearance rates in the supine position were low to normal
in three patients, ranging from 951 to 1530 liters/day;
these three patients had an arteriovenous polytef (Teflon)-
silastic shunt inserted in the forearm or lower leg. In con-
trast, the supine metabolic clearance rate was elevated,
ranging from 2173 to 3540 liters/day, in the other three
patients who had large arteriovenous fistulae, with the
highest value in the patient with both a polytef-silastic
shunt and a fistula. The standing position reduced the
plasma clearance of aldosterone by 16.4 to 49.4%. Secre-
tion rates in the standing position increased 25 to 137% in
four patients (dialysate potassium concentration, 1 to
2 mEq/liter) and did not change in the other two patients
(potassium-free dialysate).
Correlation between baseline plasma aldosterone concen-
trations or aldosterone responsiveness and total time on
hemodialysis or postnephrectomy interval. There was no
apparent correlation between baseline plasma aldosterone
concentrations, or responsiveness of aldosterone to angio-
tensin or ACTH and the interval which elapsed between
bilateral nephrectomy and the time these studies were
performed (range, 2 weeks to 35 months). There was also
no apparent correlation between the two aldosterone in-
dexes, and total duration of hemodialysis treatment in
these patients (range, 1 to 40 months).
Discussion
Although several components may be important, the
renin-angiotensin system is generally considered to play
a major role in the control of aldosterone secretion [4, 6, 7].
However, the question as to whether the adrenotrophic
action of angiotensin II is an auxiliary mechanism or is
essential for normal aldosterone production under basal
and stimulatory conditions in man has not been clarified.
Following bilateral nephrectomy, plasma renin activity
falls rapidly to low or undetectable values within 24 hours
after surgery [18, 19], and it remains unmeasurable in most
patients [8, 18—21]. In the present study, very low levels
of plasma renin activity were detectable in only one of
twelve anephric subjects during baseline conditions and
following various stimuli. These results provide the neces-
sary conditions for evaluation of the regulation of aldos-
terone in the absence of a dynamically functioning renin-
angiotensin system.
A clear-cut relationship was observed in our study be-
tween the values of plasma potassium and aldosterone.
This conclusion is supported by a) parallel increases in the
concentrations of plasma potassium and aldosterone on
the third and fourth days following hemodialysis as com-
pared with the first two days after dialysis (F< 0.05), b) a
significant correlation between plasma potassium and
aldosterone values under baseline conditions (r=0.38;
P<0.O1) and c) a significant correlation between acute
changes in plasma potassium and aldosterone concentra-
tions following oral loading of potassium and hemodialysis
(r =0.64; P< 0.0001). The first two findings are in agree-
ment with data previously reported by Bayard et al [8],
who, however, reported a much closer correlation of
plasma potassium and aldosterone values under baseline
conditions. Our observations in anephric subjects extend
a recent study in normal man by Diuhy et al [22] indicating
that aldosterone secretion is acutely responsive to small
changes of plasma potassium concentration within the
physiologic range. However, the aldosterone response for
a given increase in plasma potassium was considerably
greater in Dluhy's normal subjects than in our nephrectom-
ized subjects.
In contrast to the report by McCaa et al [9], volume de-
pletion by ultrafiltration hemodialysis (weight loss of 0.5 to
5.6 kg) did not increase the plasma aldosterone concentra-
tion. Mitra et al [10], however, noted no change in plasma
aldosterone following more gradual dehydration with pen-
toneal dialysis. Our results are consonant with the concept
that the stimulatory effect of volume depletion on aldo-
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Fig. 5. Effect of potassium concentration in dialysate used for
maintenance dialysis on baseline levels and response of plasma
aldosterone concentration to posture and administration of angio-
tensin amide and corticotropin.
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sterone secretion is dependent on the renin-angiotensin
system [1, 23, 24].
Experimental data suggest that marked reduction in the
sodium concentration of adrenal perfusate or sodium de-
pletion stimulate aldosterone release [2, 3, 25]. In the pre-
sent report, neither the small decreases in serum sodium
concentrations (1 to 3.7 mEq/liter) nor negative sodium
balance (140 to 332 mEq) with stable plasma potassium
concentrations following ultrafiltration hemodialysis had
an apparent effect on plasma aldosterone values. In another
study in anephric man, no change in plasma aldosterone
concentration occurred following the removal of sodium
(170 to 330 mEq) by peritoneal dialysis [7].
The responsiveness of plasma aldosterone concentration
to exogenous angiotensin II and ACTH administration was
diminished or absent in the majority of patients (Tables 1
and 2). In contrast, both baseline plasma cortisol concen-
tration and its response to ACTH infusion were consistently
normal.
In anephric man, low concentrations and diminished
responsiveness of aldosterone are probably partly due to
the absence of circulating angiotensin and its adrenotrophic
effect. This concept is supported by a) the observation of
parallel decreases in plasma renin activity and aldosterone
concentrations immediately following bilateral nephrec-
tomy [26], b) the finding of significantly lower plasma
aldosterone concentrations in anephric subjects as com-
pared to nonnephrectomized hemodialysis patients with
measurable circulating renin activity levels [26] and c) the
recent description of hyporeninemic hypoaldosteronism in
patients with chronic renal failure [27,28].
In addition to the clear-cut relationship between baseline
plasma aldosterone and potassium concentrations, aldo-
sterone responsiveness to stimuli in anephric patients also
seems to be influenced by changes in potassium metabolism.
In the present report, increases in plasma aldosterone
concentration were observed in response to ACTH and
angiotensin infusion following potassium repletion in pre-
viously unresponsive subjects. In addition, normal aldos-
terone responses to ACTH infusion were previously re-
ported in anephric subjects with hyperkalemia [10]. These
data are in agreement with experimental evidence suggest-
ing an important role of potassium in the modulation of
aldosterone responsiveness to various stimuli [29—311.
An additional factor which must be considered in the
regulation of aldosterone in hemodialysis patients is heparin,
which has been reported to interfere with aldosterone secre-
tion in normal subjects and in several diseased states
[32—34]. Four-hour heparin infusions in equivalent dosage
and rate to that used during hemodialysis did not greatly
decrease plasma aldosterone concentrations and, therefore,
cannot account for the decreases observed following low
potassium hemodialysis (Fig. 3). Nevertheless, it is possible
that the long-term administration of heparin in these sub-
jects undergoing chronic hemodialysis (1 to 40 months)
may have contributed to the observed alterations in aldo-
sterone metabolism.
Change from the supine to the upright position is known
to increase plasma renin activity and aldosterone concen-
trations in normal subjects [35, 36]. The present data de-
monstrate postural increases in plasma aldosterone con-
centration in the absence of kidneys and measurable circu-
lating renin activity, as also noted recently in anephric sub-
jects by Mitra et al [10], but in contrast to the results of
Bayard et al [8]. In the present study no clear-cut postural
changes could be observed in nine instances, but increases
of more than fifty to four hundred % were seen in the
other ten instances, one of these during ACTH suppression
with dexamethasone. There were no consistent accompany-
ing changes in plasma cortisol to suggest altered ACTH
activity or electrolyte concentration as a stimulus for aldo-
sterone release during standing.
However, an orthostatic increase in plasma aldosterone
concentration could be solely due to a postural fall in
hepatic blood flow and metabolism of the mineralocorti-
coid [14, 15]. Measurements in six anephric subjects showed
supine metabolic clearance rates ranging from a low value
of 950 to a markedly elevated value of 3540 liters/day
(Table 4). The three patients with arteriovenous polytef-
silastic shunts had normal to low clearance rates, but
elevated values were observed in three subjects with large
arteriovenous fistulae, with the highest aldosterone clear-
ance rate in the patient with both a shunt and a fistula
(Table 4). Since the patients with the high basal clearance
rates were those with a more extensive arteriovenous short-
circuit, it is probable that the high aldosterone clearance
rate in these cases was due to an associated increase in
cardiac output and liver blood flow.
The upright position reduced aldosterone clearance rates
in the anephric subjects 16 to 50 % (Table 4); this is
comparable to the orthostatic changes reported in normal
man [15]. Moreover, in the anephric patients, the ortho-
static decreases in metabolic clearance rate could not fully
account for the accompanying increases in plasma aldo-
sterone concentration; in four of the six patients studied,
the change from the supine to the upright posture caused
an increase in the calculated blood production rate of 25 to
137% (Table 4). These findings are consistent with postural
stimulation of aldosterone secretion by a factor other than
the renin-angiotensin system, ACTH or plasma potassium
and sodium concentrations. Nevertheless, despite a lack
of correlation with plasma potassium concentrations, the
data suggest that potassium has a role in this postural
response. The majority of the "nonresponders" were under-
going maintenance hemodialysis using potassium-free dialy-
sate, which has been shown to cause potassium depletion
[37], whereas the "responders" were generally dialyzed
against potassium-containing dialysate. Moreover, potas-
sium repletion in one patient changed postural unrespon-
siveness into responsiveness (Fig. 5).
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It was hoped that anephric man might provide an easily
understood model for aldosterone control in the absence
of a functioning renin-angiotensin system. Previous studies
[8—101 have proceeded with this as an underlying tenet. The
present study clearly indicates that this model is a very
complex one. Potassium, both acutely and chronically,
appears to alter aldosterone production. Potassium may
play a stimulatory role as well as alter the ability of the
adrenal cortex to respond to exogenous and endogenous
stimuli. However, the roles of such factors as the concen-
tration of plasma sodium, pituitary ACTH and heparin,
singly or in combination, although not apparent in the
present study, remain to be further elucidated. In addition,
the mechanism of the postural augmentation of aldosterone
secretion seen in some anephric subjects is as yet unex-
plained.
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